Virtus LifeSci Biotech Products ETF Rating $98.20 +0.61 (+0.63%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.66Holdings in BBP have an aggregate rating of Moderate Buy based on 302 analyst ratings issued in the past year covering 25 companies (40.4% of the portfolio).BBP Aggregate Price Target$98.20High Prediction$98.20Average Prediction$98.20Low Prediction$98.20Holdings in BBP have an aggregate price target of $98.20 and a range of $98.20 to $98.20 covering 25 companies (40.4% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.83%MRNAModerna$68.28+1.2%1.8264 of 5 stars1.82$38.27 -44.0%171.78%PGENPrecigen$5.123.1346 of 5 stars2.33$12.50 144.1%6Positive News1.74%AGIOAgios Pharmaceuticals$39.87-0.1%1.6518 of 5 stars2.45$42.56 6.7%11Analyst Revision1.71%RAREUltragenyx Pharmaceutical$31.71-1.0%3.6118 of 5 stars2.83$58.41 84.2%18Positive News1.69%MIRMMirum Pharmaceuticals$121.00+0.1%2.8139 of 5 stars2.93$143.40 18.5%151.68%RYTMRhythm Pharmaceuticals$109.69-0.2%2.7702 of 5 stars2.76$138.29 26.1%17Positive News1.66%IBRXImmunityBio$7.73-1.9%3.0748 of 5 stars2.71$14.20 83.7%71.63%ACADACADIA Pharmaceuticals$25.92+1.7%4.8771 of 5 stars2.65$32.94 27.1%17Positive News1.63%KURAKura Oncology$11.33+0.8%2.8194 of 5 stars2.69$25.46 124.7%13News CoveragePositive News1.62%ASNDAscendis Pharma A/S$268.57+1.1%4.3144 of 5 stars3.00$295.67 10.1%19Positive News1.61%LGNDLigand Pharmaceuticals$296.26-1.6%3.272 of 5 stars2.88$304.00 2.6%8News CoveragePositive NewsAnalyst Forecast1.60%RIGLRigel Pharmaceuticals$41.18+0.0%3.8238 of 5 stars2.33$54.50 32.3%61.60%DNLIDenali Therapeutics$23.02+1.6%3.2669 of 5 stars2.81$34.75 51.0%16News CoverageAnalyst Forecast1.59%CYTKCytokinetics$82.62+0.8%2.7504 of 5 stars2.91$99.90 20.9%22News CoverageInsider TradeOptions Volume1.59%KRYSKrystal Biotech$350.24+3.2%2.4606 of 5 stars2.83$360.67 3.0%12Analyst Forecast1.58%SNDXSyndax Pharmaceuticals$23.52-2.5%2.5861 of 5 stars2.92$42.55 80.9%13News CoverageAnalyst Forecast1.56%NUVBNuvation Bio$5.89-0.2%3.2437 of 5 stars2.64$12.38 110.1%111.55%KNSAKiniksa Pharmaceuticals International$61.69-0.5%3.0664 of 5 stars3.00$65.14 5.6%9Analyst Downgrade1.55%BCRXBioCryst Pharmaceuticals$9.41-3.4%3.1495 of 5 stars2.67$20.80 121.0%12Positive NewsAnalyst Forecast1.55%GERNGeron$1.42+2.9%1.9375 of 5 stars2.20$4.00 181.7%5News CoverageAnalyst Revision1.54%ROIVRoivant Sciences$34.89-0.1%1.7714 of 5 stars2.75$33.59 -3.7%121.53%IRWDIronwood Pharmaceuticals$4.00+0.5%2.7518 of 5 stars2.71$6.23 55.8%7News Coverage1.53%TGTXTG Therapeutics$56.41+2.8%3.0371 of 5 stars2.56$53.33 -5.5%9Trending NewsAnalyst ForecastAnalyst Revision1.53%TVTXTravere Therapeutics$56.74-0.6%1.9813 of 5 stars2.69$52.08 -8.2%13Positive News1.53%XERSXeris Biopharma$8.70+5.1%3.5093 of 5 stars2.43$10.80 24.1%7News CoveragePositive News This page (NYSEARCA:BBP) was last updated on 7/15/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
